🔗 Permalink

Inventor profile of:

Stephen J. Haggarty

City:

Gloucester, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2024-11-07

Top Assignees for applications by Stephen J. Haggarty

The entities that hold a legal rights for patent applications filed by inventor Haggarty Stephen J.:

The General Hospital Corporation 20 Boston, MA United States
The General Hospital Corporation d/b/a Massachusetts General Hospital 16 Boston, MA United States
Dana-Farber-Cancer Institute, Inc. 12 Boston, MA United States
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 12 Cambridge, MA United States
THE BROAD INSTITUTE, INC. 10 Cambridge, MA United States
President and Fellows of Harvard College 4 Cambridge, MA United States
The General Hospital Corporation d/b/a 1 Boston, MA United States
Vesigen, Inc. 1 Cambridge, MA United States

Recent patent applications by Haggarty Stephen J.

Stephen J. Haggarty from Gloucester, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-07

US20240366594A1

Human necessities

Small Molecule Inhibitors of Formation of Neutrophil-Derived Extracellular Traps (NETosis) and Uses Thereof

#2 | 2024-03-21

US20240091213A1

Human necessities

COMPOUNDS FOR TAU PROTEIN DEGRADATION

#3 | 2023-07-20

US20230227852A1

Chemistry; metallurgy

ARRDC1-MEDIATED MICROVESICLE-BASED DELIVERY TO THE NERVOUS SYSTEM

#4 | 2023-07-20

US20230226195A1

Human necessities

TARGETED ABERRANT ALPHA-SYNUCLEIN SPECIES AND INDUCED UBIQUITINATION AND PROTEOSOMAL CLEARANCE VIA CO-RECRUITMENT OF AN E3-LIGASE SYSTEM

#5 | 2023-05-04

US20230133538A1

Chemistry; metallurgy

TARGETED DEGRADERS OF ABERRANT TAU BASED ON THE PET TRACER PBB3

#6 | 2022-05-26

US20220160702A1

Human necessities

KINASE INHIBITORS AND METHODS OF USE THEREOF

#7 | 2022-03-03

US20220064151A1

Chemistry; metallurgy

ACTIVATORS OF CLASS I HISTONE DEACETYLASES (HDACS) AND USES THEREOF

#8 | 2021-06-10

US20210171429A1

Chemistry; metallurgy

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

#9 | 2021-05-27

US20210154184A1

Human necessities

COMPOUNDS FOR TAU PROTEIN DEGRADATION

#10 | 2020-03-19

US20200087236A9

Chemistry; metallurgy

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

#11 | 2020-02-27

US20200061050A9

Human necessities

Kinase inhibitors and methods of use thereof

#12 | 2019-07-11

US20190211000A1

Chemistry; metallurgy

Activators of class I histone deacetylases (HDACs) and uses thereof

#13 | 2019-06-13

US20190175584A1

Human necessities

KINASE INHIBITORS AND METHODS OF USE THEREOF

#14 | 2019-01-08

US15401902

Human necessities

Treatment of protein degradation disorders

#15 | 2018-10-11

US20180290960A1

Chemistry; metallurgy

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

#16 | 2018-04-12

US20180099977A1

Chemistry; metallurgy

Inhibitors of histone deacetylase

#17 | 2018-03-15

US20180072671A1

Chemistry; metallurgy

Inhibitors of histone deacetylase

#18 | 2018-01-18

US20180016282A9

Chemistry; metallurgy

INHIBITORS OF HISTONE DEACETYLASE

#19 | 2017-08-03

US20170217955A9

Chemistry; metallurgy

INHIBITORS OF HISTONE DEACETYLASE

#20 | 2016-12-01

US20160347761A1

Chemistry; metallurgy

Inhibitors of histone deacetylase

#21 | 2016-09-29

US20160280693A1

Chemistry; metallurgy

Activators of class I histone deacetlyases (HDACs) and uses thereof

#22 | 2016-09-22

US20160272579A1

Chemistry; metallurgy

Inhibitors of histone deacetylase

#23 | 2016-09-01

US20160251351A1

Chemistry; metallurgy

Inhibitors of histone deacetylase

#24 | 2016-02-25

US20160051619A1

Human necessities

Treatment of protein degradation disorders

#25 | 2015-11-05

US20150313890A1

Human necessities

Kinase inhibitors and methods of use thereof

#26 | 2015-07-09

US20150191427A1

Chemistry; metallurgy

Inhibitors of histone deacetylase

#27 | 2015-07-09

US20150190411A1

Human necessities

ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL

#28 | 2014-04-17

US20140107141A1

Chemistry; metallurgy

Kinase inhibitors and methods of use thereof

#29 | 2013-01-03

US20130004517A1

Human necessities

DISC-1 pathway activators in the control of neurogenesis

#30 | 2006-10-26

US20060239909A1

Human necessities

Treatment of protein degradation disorders

InventorID:

1218483 ⎘